Liquid Biopsy
News and reporting on cell-free DNA testing.
Cancer Diagnostics Firm Syantra Raises $3.6M in Series A-1 Round
The University of Calgary spinout aims to commercialize a liquid biopsy test that measures mRNA biomarkers for the early detection of breast cancer.
Pillar Biosciences, AstraZeneca Partner on Liquid Biopsy Testing in Europe
AstraZeneca has partnered with several other firms on liquid biopsies, including Angle, Sophia Genetics, IMBdx, and Guardant Health.
Tethis, Weill Cornell Partner for CTC, cfDNA Analysis of Blood Samples in Early Breast Cancer
Weill Cornell researchers will use Tethis' platform to prepare blood samples for cell-free DNA and circulating tumor cell analysis.
Foundation Medicine Nets FDA Approval for Tissue, Liquid NGS CDx for Lynparza Combo
The FDA approved FoundationOne CDx and FoundationOne Liquid for identifying BRCA1/2-mutated mCRPC patients eligible for Lynparza, Zytiga, and a steroid.
Caris Life Sciences, EDX Medical Ink Molecular Profiling Distribution Agreement
EDX Medical has the exclusive rights to distribute Caris' portfolio of molecular profiling services throughout the UK and four Nordic countries.